ELYMBUS Trademark

Trademark Overview

On Monday, September 5, 2022, a trademark application was filed for ELYMBUS with the United States Patent and Trademark Office. The USPTO has given the ELYMBUS trademark a serial number of 79351758. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by LABORATOIRES THEA. The ELYMBUS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-glaucoma preparations for ophthalmic use
elymbus

General Information

Serial Number79351758
Word MarkELYMBUS
Filing DateMonday, September 5, 2022
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7238534
Registration DateTuesday, December 12, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2023

Trademark Statements

Goods and ServicesAnti-glaucoma preparations for ophthalmic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRES THEA
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameLABORATOIRES THEA
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameLABORATOIRES THEA
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 19, 2024NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, March 13, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 13, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 12, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 26, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023PUBLISHED FOR OPPOSITION
Monday, September 25, 2023NOTIFICATION PROCESSED BY IB
Wednesday, September 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 6, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 6, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 21, 2023REFUSAL PROCESSED BY IB
Monday, August 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 3, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 20, 2023ASSIGNED TO EXAMINER
Tuesday, December 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 11, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

elymbus ophthalmic preparations glaucoma anti